Continue Reading... Canopy Growth or Tilray Brands: Which Stock Is More Likely to Be a Millionaire Maker?
Posted in Cannabis Stocks

Canopy Growth or Tilray Brands: Which Stock Is More Likely to Be a Millionaire Maker?

Both companies have positioned themselves to capitalize on potential opportunities in the cannabis market. However, there is significant uncertainty ahead,…

Continue Reading... SNDL stock loses 31% in six months: Should you buy the dip?
Posted in Cannabis Stocks

SNDL stock loses 31% in six months: Should you buy the dip?

Shares of SNDL Inc. SNDL, one of the largest vertically integrated cannabis players in Canada, have been declining steadily over…

Continue Reading... Canaccord is Bullish on Cronos Group Inc. (CRON)
Posted in Cannabis Stocks

Canaccord is Bullish on Cronos Group Inc. (CRON)

Cronos Group Inc. (NASDAQ:CRON) is among the 7 Best Cannabis Stocks to Invest In Now. Cronos Group Inc. (NASDAQ:CRON) is…

Continue Reading... Canaccord Analyst Initiates Coverage on Tilray Brands, Inc. (TLRY)
Posted in Cannabis Stocks

Canaccord Analyst Initiates Coverage on Tilray Brands, Inc. (TLRY)

Tilray Brands, Inc. (NASDAQ:TLRY) is among the 7 Best Cannabis Stocks to Invest In Now. Tilray Brands, Inc. (NASDAQ:TLRY) is…

Continue Reading... Should you forget Canopy Growth and buy this magnificent cannabis stock instead?
Posted in Cannabis Stocks

Should you forget Canopy Growth and buy this magnificent cannabis stock instead?

The cannabis company’s shares have plummeted by more than 40% over the past year.

Continue Reading... 7 Best Cannabis Stocks to Invest In Now
Posted in Cannabis Stocks

7 Best Cannabis Stocks to Invest In Now

Organigram Global Inc. (NASDAQ:OGI) is among the Best Marijuana Stocks.

Continue Reading... Is Tilray stock going to $0?
Posted in Cannabis Stocks

Is Tilray stock going to $0?

The company isn’t in good financial shape, and there’s still plenty of risk with the stock.

Continue Reading... This Canadian cannabis stock is a buy, analyst says
Posted in Cannabis Stocks

This Canadian cannabis stock is a buy, analyst says

Research Capital analyst Andre Greg McLeish has reiterated a “Buy” rating and $3.50 price target on Cannara Biotech …

Continue Reading... Should you sell your Aurora Cannabis stock?
Posted in Cannabis Stocks

Should you sell your Aurora Cannabis stock?

Roth Capital Markets analyst Bill Kirk reiterated a “Neutral” rating on ACB and lowered his 12-month price target to C$5.00…

Continue Reading... Should you buy, hold or sell ACB stock post Q3 earnings release?
Posted in Cannabis Stocks

Should you buy, hold or sell ACB stock post Q3 earnings release?

Aurora Cannabis ACB recently reported its third-quarter results for fiscal 2026 (year ending March 2026). Both earnings and sales beat…